Literature DB >> 18245520

Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention.

J Thomas Parsons1, Jill Slack-Davis, Robert Tilghman, W Gregory Roberts.   

Abstract

The tumor microenvironment plays a central role in cancer progression and metastasis. Within this environment, cancer cells respond to a host of signals including growth factors and chemotactic factors, as well as signals from adjacent cells, cells in the surrounding stroma, and signals from the extracellular matrix. Targeting the pathways that mediate many of these signals has been a major goal in the effort to develop therapeutics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245520     DOI: 10.1158/1078-0432.CCR-07-2220

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  62 in total

1.  Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.

Authors:  Colin Walsh; Isabelle Tanjoni; Sean Uryu; Alok Tomar; Ju-Ock Nam; Hong Luo; Angelica Phillips; Neela Patel; Cheni Kwok; Gerald McMahon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

2.  PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.

Authors:  Isabelle Tanjoni; Colin Walsh; Sean Uryu; Alok Tomar; Ju-Ock Nam; Ainhoa Mielgo; Ssang-Taek Lim; Congxin Liang; Marcel Koenig; Connie Sun; Neela Patel; Cheni Kwok; Gerald McMahon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

3.  Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.

Authors:  Geoffrey Kim; Ben Davidson; Ryan Henning; Junbai Wang; Minshu Yu; Christina Annunziata; Thea Hetland; Elise C Kohn
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

Review 4.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

Review 5.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

6.  Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.

Authors:  Huaping Fan; Xiaofeng Zhao; Shaogang Sun; Ming Luo; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

7.  Effects of TRPM8 on the proliferation and angiogenesis of prostate cancer PC-3 cells in vivo.

Authors:  Guangbin Zhu; Xinghuan Wang; Zhonghua Yang; Hong Cao; Zhe Meng; Yongzhi Wang; Dong Chen
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

Review 8.  RhoGEFs in cell motility: novel links between Rgnef and focal adhesion kinase.

Authors:  N L G Miller; E G Kleinschmidt; D D Schlaepfer
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

Review 9.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

Review 10.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.